Match Document Document Title
6982168 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer  
The present invention relates to immortalized, malignant, human, adult prostate epithelial cell lines or cell lines derived therefrom useful in the diagnosis and treatment of prostate cancer. More...
6982171 Cell motility and chemotaxis test device and methods of using same  
The present invention discloses a device for monitoring chemotaxis or chemoinvasion including a housing comprising: a support member and a top member, the top member mounted to the support member...
6972194 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic and xenogenic cells  
The invention relates to the field of medicine and more particularly it relates to the problem of vaccination against tumor cells and vaccinotherapy of oncological diseases, and also to a method of...
6969610 Methods of modifying cell structure and remodeling tissue  
Disclosed is a method of modifying cell structure which includes: increasing the intracellular concentration of biliverdin reductase, or a fragment or variant thereof, in a mammalian cell under...
6969532 Compounds inhibiting COX-2 and iNOS promoter activities  
A new chemical compound for treating human inflammatory diseases, tissue damage, stroke, septic shock and cancer. This chemical compound is produced from a process including the following steps:...
6969583 Method for detecting variant HBV  
The present invention relates generally to an assay for detecting variant Hepatitis B viruses (HBVs) which exhibit altered sensitivity to agents. The variant HBVs are delivered to cells using a...
6964855 Peptides for detection to Anaplasma phagocytophilum  
The invention provides compositions and methods for the detection and quantification of A. phagocytophilum (formerly known as Ehrlichia equi ) antibodies and antibody fragments.
6956114 Sulfurylase-luciferase fusion proteins and thermostable sulfurylase  
The present invention relates to the field of DNA recombinant technology. More specifically, this invention relates to fusion proteins comprising an ATP generating polypeptide joined to a...
6955898 Targeting pharmaceutical agents to injured tissues  
The present invention provides new compositions and methods to induce therapeutic angiogenesis locally utilizing a collagen binding domain to target an angiogenesis modulating agents. Fusion...
6955802 Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube  
Provided are genetically engineered cells comprising a neural stem cell and retroviral expression system in the neural stem cell, which is capable of expressing homeodomain transcription factor...
6949381 Immortalized human skin cell lines and novel serum-free medium useful for the production thereof  
The present invention relates to improved continuous (immortalized) cell lines, in particular keratinocytes and melanocytes derived from normal human skin tissue. The present invention also relates...
6949690 Methods of assessing the effect of a gene of interest on human prostate cancer progression  
The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
6943016 Human adult astrocytes, their preparation and uses thereof  
The invention provides an essentially pure preparation of human adult astrocytes, and a method of producing same. The purified astrocytes are useful for the treatment of neurodegenerative disorders...
6936593 Method of down-regulating gene expression  
Disclosed is a method of down-regulating the expression of a gene in an animal, wherein a pharmacological formulation comprising a chimeric oligonucleotide complementary to the gene is orally...
6927060 Methods to prepare and use epidermal stem cells  
A method to prepare epidermal stem cells, and isolated epidermal stem cells, is provided. Also provided are methods of using epidermal stem cells, e.g., for cell based therapies.
6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors  
AAV vectors may have utility for gene therapy but heretofore a significant obstacle has been the inability to generate sufficient quantities of such recombinant vectors in amounts that would be...
6919209 Method of genetically modifying very primitive quiescent human hematopoietic stem cells  
This invention relates to a method for transducing extremely primitive hematopoietic stem cells with high efficiency, using an adeno-associated vector. This vector stably transforms highly...
6916642 Vertebrate telomerase genes and proteins and uses thereof  
Nucleic acid molecules encoding vertebrate telomerase are provided. Gene products, expression vectors and host cells suitable for expressing telomerase are also provided. Methods for identifying...
6916655 Cultured skin and method of manufacturing the same  
A cultured skin and a grafting cultured skin sheet are provided, each of which is a cultured reconstructive skin with a high take rate using cells collectable from cells originated from tissue...
6913925 Human mesencephalon cell lines and methods of use therefor  
Conditionally-immortalized human mesencephalon cell lines are provided. Such cell lines, which may be clonal, may be used to generate neurons, including dopaminergic neurons. The cell lines and/or...
6913924 Population of interferon producing cells  
Dendritic cell subsets, and various methods of making and using same are provided. In particular, methods for making a defined subset of dendritic cells are provided.
6913927 Non-adenoviral gene product-based complementing cells for adenoviral vectors  
The invention provides cells and methods of using the cells for the propagation of replication-deficient adenoviral vectors. The cells comprise at least one heterologous nucleic acid sequence which...
6911324 Induction of beta cell differentiation in human cells  
The present invention provides methods for inducing insulin gene expression in cultured pancreas cells, the method comprising contacting a culture of endocrine pancreas cells expressing a PDX-1...
6908764 Recombinant human cell for bone and cartilage cell formation  
The invention relates to a recombinant human cell of undifferentiated mesenchyma for bone and cartilage cell formation, the human cell having the ability to express Tbr-1, Brachyury or another...
6905875 Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells  
A non-disruptive three-dimensional culture system allows cell growth and proliferation in three dimensions, permitting cell splitting without subjecting cells to disruptive conditions that affect...
6905831 Real time measurement of cellular responses  
Living cells can be stably modified to emit different colors from the cytoplasm and nucleus, thus permitting analysis of the status of said cells and the effect of agents on said cells either by...
6902929 Retroviral vectors, methods for their preparation and their use for gene transfer into CD4-positive cells  
The invention relates to the production and use of retroviral vectors for cell specific gene transfer, specially to a production method of retroviral vectors containing capsid particles of murine...
6900053 Antisense modulation of fibroblast growth factor receptor 2 expression  
Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 2. The compositions comprise antisense compounds, particularly...
6900051 Process for obtaining mammalian insulin secreting cells in vitro and their uses  
The present invention relates to a process for obtaining mammalian insulin secreting cells in vitro, characterized in that it contains the following steps: a) preparation of the mammalian...
6897061 Transdifferentiation of glial cells  
A process for generating multipotent cells from glial cells using in vitro techniques to dedifferentiate fetal or adult mammalian glial cells into multipotent cells. The multipotent cells may...
6897064 Cell or tissue-culturing carrier, and culturing method  
A cell or tissue-culturing carrier which can effectively regenerate an intended a cell or tissue, while suppressing an excessive growth of fibroblasts, and a method of culturing a cell or tissue by...
6897045 Adeno-associated virus vectors  
The invention provides an isolated and purified DNA molecule comprising at least one DNA segment, a biologically active subunit or variant thereof, of a circular intermediate of adeno-associated...
6887706 Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells  
A method of differentiating embryonic stem cells into neural precursor cells is disclosed. In one embodiment the method comprises the steps of (a) obtaining an embryonic stem cell culture, (b)...
6887707 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA  
The present invention is directed to the identification and use of ribonucleoside analogs to induce the mutation of an RNA virus, including BVDV, HIV and HCV, or a virus which otherwise replicates...
6884621 Method and carrier for culturing multi-layer tissue in vitro  
The present invention provides method and carrier for culturing multi-layered tissue in vitro, wherein few amounts of tissue blocks and cells are positioned within a porous multi-layer carrier...
6881413 Humanized biomaterials, a process for their preparation and their applications  
The invention relates to humanized biomaterial comprising a porous biocompatible composite material customized and implanted with monocyte derived cells preferably with macrophages.
6878383 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions  
The invention provides a composition for promoting regeneration of tissue which has degenerated in a subject as a result of a disease or disorder and a method of using the composition is provided....
6878687 Protein HMAAD57  
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells,...
6878545 Method for separating viable cells from cell suspensions  
The invention relates to a method of separating viable cells from cell suspensions using hydrocyclones, which method can, especially, be carried out continuously.
6872569 In vitro production of haploid germ cells  
The present invention relates to a method of in vitro spermatogenesis involving Sertoli cells and diploid germ cells from a testis of a male mammal to yield differentiated haploid spermatids. The...
6863884 Pseudotyped retroviral vectors  
The present invention provides pseudotyped retroviral vectors and packaging systems and methods of using such vectors for retroviral-mediated gene transfer. In particular, the present invention...
6858582 Composition containing porous microparticle impregnated with biologically-active compound for treatment of infection  
Methods and reagents are provided for specifically targeting biologically active compounds such as antiviral and antimicrobial drugs, or prodrugs containing the biologically active compound to...
6855519 Methods for enhancing the production of interferon in cell culture  
Methods for enhancing the production of interferons in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain inducers of interferon production,...
6852520 DSP-2 dual-specificity phosphatase  
Compositions and methods are provided for the treatment of conditions associated with cell proliferation, cell differentiation and cell survival. In particular, the dual-specificity phosphatase...
6852531 Compositions and methods for reproducing and modulating mammalian messenger RNA decapping  
An in-vitro system in which mammalian messenger RNA decapping occurs is provided, for use in identifying modulators, deficiencies, and other aspects of the regulation of RNA turnover.
6846674 Genetically modified fibroblast cells  
The invention relates to genetically modified fibroblast cells which comprise the following properties: (a) a gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated...
6844192 Adenovirus E4 protein variants for virus production  
A method of packaging a recombinant viral vector is carried out by: (a) providing a packaging cell, the packaging cell containing and expressing a nucleic acid encoding a mutant adenovirus E4orf6...
6841151 Chondrocyte cell-lines  
The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions and also for developing skeletal tissue for use in repair and/or replacement...
6838284 Cell culture medium containing growth factors and L-glutamine  
The invention relates to a culture medium for culturing cells, in particular human cells in a process for tissue engineering bone. The medium comprises glucose, a mineral, a vitamin, a growth...
6838262 Isolated DNA molecule encoding rank ligand  
Isolated ligands, DNAs encoding such ligands, and pharmaceutical compositions made therefrom, are disclosed. The isolated ligands can be used to regulate an immune response. The ligands are also...